Temozolomide or Selumetinib in Treating Patients With Metastatic Melanoma of the Eye

Clinical trial NCT01143402 · COMPLETED

Trial details

NCT number: NCT01143402
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Iris Melanoma Medium/Large Size Posterior Uveal Melanoma Ocular Melanoma With Extraocular Extension Recurrent Uveal Melanoma Small Size Posterior Uveal Melanoma Stage IV Uveal Melanoma

Start date: 2010-06-01
Primary completion: 2016-05-01
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.